Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom Thomas

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Cancer Research|March 10, 2016
CRM1 Inhibition Promotes Cytotoxicity in Ewing Sarcoma Cells by Repressing EWS-FLI1-Dependent IGF-1 SignalingHaibo Sun, De-Chen Lin, Qi Cao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2016
Incorporation of Next-Generation Sequencing into Routine Clinical Care to Direct Treatment of Head and Neck Squamous Cell CarcinomaNicole G Chau, Yvonne Y Li, Vickie Y Jo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 6, 2018
Genomic Correlates of Response to Everolimus in Aggressive Radioiodine-refractory Thyroid Cancer: A Phase II StudyGlenn J Hanna, Naifa L Busaidy, Nicole G Chau, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 13, 2020
Nonsteroidal Antiinflammatory Drugs and Susceptibility to COVID-19Joht Singh Chandan, Dawit Tefra Zemedikun, Rasiah Thayakaran, et al.
JCO Oncology Advances|April 2, 2026
Functional impact of transoral surgery and risk-based adjuvant therapy in human papillomavirus-associated oropharyngeal cancer: swallowing outcomes from ECOG-ACRIN E3311Katherine A Hutcheson, Yael Flamand, Beatrice Manduchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2016
Genomic Heterogeneity and Exceptional Response to Dual Pathway Inhibition in Anaplastic Thyroid CancerWilliam J Gibson, Daniel T Ruan, Vera A Paulson, et al.
Nature Medicine|October 22, 2021
IL-1-driven stromal-neutrophil interactions define a subset of patients with inflammatory bowel disease that does not respond to therapiesMatthias Friedrich, Mathilde Pohin, Matthew A Jackson, et al.
Nature Immunology|October 22, 2024
A longitudinal single-cell atlas of anti-tumour necrosis factor treatment in inflammatory bowel diseaseTom Thomas, Matthias Friedrich, Charlotte Rich-Griffin, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Cancer Research|March 10, 2016
CRM1 Inhibition Promotes Cytotoxicity in Ewing Sarcoma Cells by Repressing EWS-FLI1-Dependent IGF-1 SignalingHaibo Sun, De-Chen Lin, Qi Cao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2016
Incorporation of Next-Generation Sequencing into Routine Clinical Care to Direct Treatment of Head and Neck Squamous Cell CarcinomaNicole G Chau, Yvonne Y Li, Vickie Y Jo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 6, 2018
Genomic Correlates of Response to Everolimus in Aggressive Radioiodine-refractory Thyroid Cancer: A Phase II StudyGlenn J Hanna, Naifa L Busaidy, Nicole G Chau, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 13, 2020
Nonsteroidal Antiinflammatory Drugs and Susceptibility to COVID-19Joht Singh Chandan, Dawit Tefra Zemedikun, Rasiah Thayakaran, et al.
JCO Oncology Advances|April 2, 2026
Functional impact of transoral surgery and risk-based adjuvant therapy in human papillomavirus-associated oropharyngeal cancer: swallowing outcomes from ECOG-ACRIN E3311Katherine A Hutcheson, Yael Flamand, Beatrice Manduchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2016
Genomic Heterogeneity and Exceptional Response to Dual Pathway Inhibition in Anaplastic Thyroid CancerWilliam J Gibson, Daniel T Ruan, Vera A Paulson, et al.
Nature Medicine|October 22, 2021
IL-1-driven stromal-neutrophil interactions define a subset of patients with inflammatory bowel disease that does not respond to therapiesMatthias Friedrich, Mathilde Pohin, Matthew A Jackson, et al.
Nature Immunology|October 22, 2024
A longitudinal single-cell atlas of anti-tumour necrosis factor treatment in inflammatory bowel diseaseTom Thomas, Matthias Friedrich, Charlotte Rich-Griffin, et al.
Pageof 7